Aspirin metabolism in pregnant women at risk of pre-eclampsia
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctor has recommended taking aspirin to lower your risk of pre-eclampsia.
- You are willing to take aspirin as directed throughout the study.
- You are less than 16 weeks pregnant at enrollment.
- You can communicate comfortably in English.
- You do not have diabetes or gestational diabetes right now.
- You do not have a bleeding disorder or take blood thinners or NSAIDs like ibuprofen.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body processes sugar and nutrients during pregnancy in women at higher risk for pre-eclampsia (a serious pregnancy condition with high blood pressure). Researchers want to understand if taking low-dose aspirin helps protect heart and metabolic health. You'll have blood tests, body composition scans, and metabolic measurements.
This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.
This trial tests whether a higher dose of aspirin (150 mg) works better than the standard dose (100 mg) to prevent preeclampsia, a serious pregnancy complication, in women with obesity who are at increased risk. If you are between 12 and 16 weeks pregnant with one baby and have a high BMI, you may be able to join.
This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.
This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.
This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.